Selection of specific aptamer against rivaroxaban and utilization for label-free electrochemical aptasensing using gold nanoparticles: first announcement and application for clinical sample analysis

HIGHLIGHTS

  • who: Rokhsareh Ebrahimi and colleagues from the Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran have published the article: Selection of Specific Aptamer against Rivaroxaban and Utilization for Label-Free Electrochemical Aptasensing Using Gold Nanoparticles: First Announcement and Application for Clinical Sample Analysis, in the Journal: (JOURNAL)
  • what: The aim of this study was to develop an electrochemical-based aptasensor method for the determination of RIV in plasma and EBC. The affinity constants of the RIV aptamers were determined using SPR in the range of 1.56 u00d7 10-9 to 8.84 . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?